Ciclosporin A (CyA) was the cornerstone of rescue medical therapy for steroid-refractory acute severe colitis until the advent of anti-TNF agents. CyA is a competitive calcinuerin inhibitor with ...
The Lindgren score was better than three other currently available scores at predicting major clinical outcomes in patients with acute severe ulcerative colitis, according to research published in ...
IBDs such as Crohn's disease (CD) and ulcerative colitis (UC) are characterized by chronic diarrhea and abdominal pain. However, many patients develop severe complications over time, such as tissue ...
Ulcerative colitis (UC) is a chronic inflammatory disease of the colon driven by an abnormal immune response. It typically begins in the rectum and spreads continuously, occasionally involving a cecal ...
Although acute severe ulcerative colitis (ASUC) is recognized as a life-threatening flare associated with elevated thrombotic risk, the extent and duration of hypercoagulability after hospital ...
Inflammatory bowel diseases (IBD), including Crohn’s disease (CD) and ulcerative colitis (UC), are chronic relapsing-remitting diseases of the gastrointestinal tract 1. Patients present with (bloody) ...
Diseases and disorders particularly that of bowels and digestive process is more common than others and colitis is one such common disease that is experienced by countless people all over the world.
Announcing a new article publication for Cardiovascular Innovations and Applications journal. Cardiovascular diseases, particularly acute myocardial infarction, are the leading cause of disability and ...
Colitis occurs when your colon, or large intestine, is inflamed. Microscopic colitis is a type of colitis that’s best identified by looking at colon cells under a microscope. The main subtypes of ...
Diarrhea is generally defined as the passage of three or more unformed stools per day, often in addition to other enteric symptoms, or the passage of more than 250 g of unformed stool per day. On the ...
Ulcerative colitis is a chronic relapsing and remitting inflammatory disorder that can generally be managed successfully with maintenance oral medications. However, approximately 15% of patients with ...